Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-31 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition +110 $51.31 $6K 60,128
2026-07-07 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −5,536 $83.58 $463K 75,018
2026-07-07 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition 10b5-1 +15,000 15,000
2026-07-07 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −15,000 $85.46 $1.3M 0
2026-07-07 BENNETT C FRANK EVP, Chief Scientific Officer Other disposition · Restricted Stock Unit 10b5-1 −15,000 12,109
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise 10b5-1 +16,463 $32.60 $537K 117,017
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise 10b5-1 +48,626 $60.89 $3.0M 165,643
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −71,600 $79.10 $5.7M 94,043
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −12,687 $79.88 $1.0M 81,356
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −802 $80.76 $65K 80,554
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −16,463 2,406
2026-03-03 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −48,626 0
2026-02-27 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition +261 $48.87 $13K 100,554
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Other disposition −0 100,293
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −20,000 $82.60 $1.7M 80,293
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise 10b5-1 +48,626 $60.89 $3.0M 128,919
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −48,626 $83.03 $4.0M 80,293
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise 10b5-1 +16,463 $32.60 $537K 96,756
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −16,463 $83.03 $1.4M 80,293
2026-02-02 BENNETT C FRANK EVP, Chief Scientific Officer Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −16,463 2,406

Page 1 of 3 · 42 trades